Levodopa is the metabolic precursor of dopamine and is the cornerstone treatment for Parkinson? disease. It crosses the blood-brain barrier and is converted to dopamine in the brain, replenishing diminished levels. It is often combined with a dopa decarboxylase inhibitor (like carbidopa) to prevent peripheral conversion. Long-term use can lead to motor fluctuations and dyskinesias.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Levodropropizine and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Levodropropizine impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Levodropropizine-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.
English
Arabic
Chinese (Simplified)
French
Japanese
Portuguese
Russian
Spanish
